Loading

Review Article Open Access
Volume 5 | Issue 2 | DOI: https://doi.org/10.33696/immunology.5.163

IL-1 in Abdominal Aortic Aneurysms

  • 1Department of Surgery, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA
  • 2Department of Cardiac Surgery, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA
  • 3Frankel Cardiovascular Center, University of Michigan School of Medicine, Ann Arbor, Michigan, USA
+ Affiliations - Affiliations

Corresponding Author

Morgan Salmon, msalmon@med.umich.edu

Received Date: March 07, 2023

Accepted Date: March 14, 2023

Abstract

Abdominal Aortic Aneurysms (AAA) remain a clinically devastating disease with no effective medical treatment therapy. AAAs are characterized by immune cell infiltration, smooth muscle cell apoptosis, and extracellular matrix degradation. Interleukin-1 (IL-1) has been shown to play role in AAA associated inflammation through immune cell recruitment and activation, endothelial dysfunction, production of reactive oxygen species (ROS), and regulation of transcription factors of additional inflammatory mediators. In this review, we will discuss the principles of IL-1 signaling, its role in AAA specific inflammation, and regulators of IL-1 signaling. Additionally, we will discuss the influence of genetic and pharmacological inhibitors of IL-1 on experimental AAAs. Evidence suggests that IL-1 may prove to be a potential therapeutic target in the management of AAA disease.

Keywords

AAA, IL-1α, IL-1β, Anakinra

Author Information X